Barry Vucsko
Senior Vice President, Strategic Development, EVERSANA INTOUCH
Expertise:
Barry Vucsko has more than 25 years of marketing, advertising, and consulting experience spanning more than 100 brands and several continents. His pharma advertising career has spanned creative, strategy and account leadership. Barry has extensive experience with HCP, Consumer and Managed Care targets, as well as Global and US launches for everything from oncology to ultra-rare and blockbuster treatments. He has a proven track record of developing integrated brand communications that achieve impact and drive business. Barry has an MBA from Indiana University’s Kelley School of Business and a BA from Columbia College Chicago.
Articles by Barry Vucsko
The Combination Crossfire: Is Your Brand Strategy Strong Enough to Align Payers, Prescribers, and Patients?
Navigating Oncology’s Combination Era Combination therapy is now the norm in oncology, with most trials exploring multi-drug regimens. Success depends not just on clinical results, but on how well your brand stands out and performs within these complex combinations. One Value Story, Three Audiences Today’s oncology marketers must master the art of translation—crafting a core […]
A New Marketing Mandate in Community Oncology
As the next wave of oncology innovation—bispecific antibodies, ADCs, and CAR-T therapies—moves from academic centers into community practices, marketers face unprecedented clinical, operational, and financial hurdles. Success now demands a shift from traditional promotion to building tailored support ecosystems that empower every practice, regardless of size or location. Our Marketing Toolkit for Community Oncology That’s […]
The Enablement Helix: An Evolving Framework for Market Success in Oncology
In today’s rapidly evolving oncology landscape, market success demands more than traditional promotional strategies – it requires a unified, cross-functional approach that empowers clinical partners and streamlines care delivery. EVERSANA’s dynamic framework, The Enablement Helix, redefines how brands engage with healthcare professionals by integrating three key strands into one seamless strategy: Breakthrough Creative […]
The Oncologist’s Next Ally: Why Cancer Is Forging the Future of Clinical AI
Step into the future of medicine, where the battle against cancer is redefining what artificial intelligence (AI) can achieve in clinical care. In The Oncologist’s Next Ally: Why Cancer Is Forging the Future of Clinical AI, discover how oncology’s urgent demands—crushing data loads, complex decision-making and the race against time—are pushing AI beyond pattern recognition […]
AI in Oncology: Acceleration, Accessibility, and Accuracy
At ESMO 2025, the conversation around artificial intelligence in oncology was impossible to ignore. From accelerating drug development to enabling remote patient monitoring, AI is completely changing cancer care— and EVERSANA has consistently leveraged these innovations to deliver smarter, faster solutions for clients. In a recent interview with pharmaphorum, Barry Vucsko, Senior Vice President, Strategic […]
AI at ESMO 2025: Navigating the New Frontier of Opportunity and Obstacles in Oncology
For the first time in its history, the European Society for Medical Oncology (ESMO) dedicated an entire track to Artificial Intelligence (AI) at its 2025 conference. For those who partner with pharmaceutical and biotech companies to bring their innovations to market, this was a landmark moment. It signaled a definitive shift from AI as a […]
Making Cutting-Edge Cancer Treatments Accessible: Advancing CAR-T Therapy to the Community Practice
This article explores the significant advancements in CAR-T therapy and its transition from academic centers to community practices. CAR-T therapy, a revolutionary treatment for certain hematological malignancies, involves modifying a patient’s T-cells to target and destroy cancer cells. Historically limited to later lines of treatment due to potential side effects and the need for individualized […]
Behind the Breakthroughs and Practice-Changing Advances: Insights from ESMO 2024
Every year, the European Society for Medical Oncology (ESMO) brings together experts from pharma, research and advocacy organizations, and healthcare providers (HCPs) to hear about the year’s biggest oncology breakthroughs. With the theme “Shaping the Future of Anticancer Therapies,” ESMO 2024 saw record crowds and focused on advancements across immuno-oncology, antibody drug conjugates (ADCs) and […]
The Necessity of Mapping the Tumor Journey for Oncology Marketers
EVERSANA INTOUCH has been pioneering a Tumor Journey that considers the complex, multi-factorial decision making that permeates every stage of oncologic patient care. Oncology Marketing has been slow in evolving to consider the complexities of diagnosis, treatment, and overall patient care decisions made by multiple stakeholders. We continue to rely on traditional patient journeys and […]